Herpes (Shingles)
Product Candidate Description
This single molecule has been used by Beech Tree's physicians and veterinarians to treat all herpes infections of man and animals. Diseases responding to this approach include herpes simplex types I and II, herpes zoster (chickenpox), shingles, infectious mononucleosis, cytomegalovirus, and Bell’s palsy. Also, herpes infections of dogs and horses also respond quickly.
Laboratory Status
In vitro work conducted by company scientists has show results suggesting that this product inhibits re-assembly of virus particles after infection of cells and virus uncoating. Confirmatory work has yet to be completed.
Clinical Status
Hundreds of patients have been successfully treated with this product by practitioners in the network developed by Dr. McMichael over the last 20 years. This product has been shown to induce responses both quickly and completely without adverse effects.
Path Forward
With a third of the world's human population expected to suffer a herpes infection this year, the market for a safe product that can be used at the same dose for any such infection is extraordinary. An IND application is in progress, using shingles as the prototype disorder from this family of diseases.